
What We’re Reading: COVID-19 Vaccine Trials to Restart; Record 2-Day Infections; Stress-Reducing Strategies
AstraZeneca and Johnson & Johnson will restart trials of their vaccine candidates against coronavirus disease 2019 (COVID-19); the United States hits a record high 2-day total of COVID-19 infections; strategies can help ease stress amid the coming election.
AstraZeneca, J&J COVID-19 Vaccine Trials to Restart
After halting clinical trials to investigate safety concerns of their respective vaccine candidates against coronavirus disease 2019 (COVID-19), both AstraZeneca and Johnson & Johnson (J&J) announced plans to restart their studies. As reported by
US Record High COVID-19 Cases in Past 2 Days
According to
Keeping Calm Amid the Election
With Election Day approaching, an article by
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.